Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Clin Dermatol. 2013 Mar;31(2):166–178. doi: 10.1016/j.clindermatol.2012.08.014

Table 1.

Studies supporting stable markers in melanoma stem cells.

SCID or
NOD/SCID
(mice with
severe
impairment
of T- and B-
cells)
NOD/LTSscid/IL2Rγnull
(mice with severe
impairment of T- and
B-cells and an
absence of NK-cells)
Rag−/−γc−/
(mice with
an
absence
of T-, B-,
and NK-
cells)
“Humanized”
mouse
models
CD20 Yes (90) NT NT NT
CD133/Prominin-1 Yes (98) No (83) NT NT
ABCG2 NT NT NT NT
ABCB5 Yes (104) No (82) NT NT
CD271/NGFR/p75NTR Yes (116) No (82, 116) Yes (115) Yes (115)
JARID1B NT No (84) NT NT

NT=not tested